Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.36 | 2e-27 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.25 | 9e-14 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-13 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-11 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.35 | 2e-11 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.33 | 1e-10 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.25 | 6e-09 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |